Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
NUVLNuvalent	$8.46bn	n/a	n/a
BPMCBlueprint Medicines	$8.37bn	n/a	n/a
ARWRArrowhead Pharmaceuticals	$8.34bn	n/a	n/a
CERECerevel Therapeutics Holdings	$8.19bn	n/a	n/a
RGCRegencell Bioscience Holdings	$8.03bn	n/a	n/a
CYTKCytokinetics	$8.03bn	n/a	n/a
MRUSMerus NV	$7.29bn	n/a	n/a
CDTXCidara Therapeutics	$6.93bn	n/a	n/a
COGTCogent Biosciences	$6.80bn	n/a	n/a
RETAReata Pharmaceuticals	$6.52bn	n/a	n/a
PRAXPraxis Precision Medicines	$6.20bn	n/a	n/a
PCVXVaxcyte	$6.08bn	n/a	n/a
PTGXProtagonist Therapeutics	$5.60bn	142	n/a
MTSRMetsera	$5.58bn	n/a	n/a
ISEEIVERIC bio	$5.51bn	n/a	n/a
CRSPCrispr Therapeutics AG	$5.42bn	n/a	n/a
LEGNLegend Biotech	$5.20bn	n/a	n/a
BLTEBelite Bio	$4.89bn	n/a	n/a
CELCCelcuity	$4.89bn	n/a	n/a
ALKSAlkermes	$4.87bn	14.63	n/a